Blue Chip Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$627K Buy
7,921
+43
+0.5% +$3.37K 0.49% 49
2020
Q2
$581K Buy
7,878
+66
+0.8% +$4.97K 0.55% 48
2020
Q1
$573K Buy
7,812
+27
+0.3% +$2.12K 0.71% 38
2019
Q4
$676K Buy
7,785
+20
+0.3% +$1.64K 0.63% 46
2019
Q3
$624K Buy
7,765
+26
+0.3% +$2.08K 0.65% 45
2019
Q2
$619K Buy
7,739
+26
+0.3% +$1.99K 0.65% 47
2019
Q1
$612K Buy
7,713
+27
+0.4% +$2.02K 0.69% 44
2018
Q4
$560K Buy
7,686
+24
+0.3% +$1.69K 0.73% 42
2018
Q3
$519K Sell
7,662
-563
-7% -$35.9K 0.52% 55
2018
Q2
$476K Sell
8,225
-822
-9% -$46.4K 0.52% 57
2018
Q1
$470K Buy
+9,047
New +$489K 0.48% 52

Other funds holding MRK

Blue Chip Wealth Management's MRK Position: Q3 2020 in Review

Blue Chip Wealth Management increased its Merck (MRK) stake by 0.55% in Q3 2020, buying an estimated $3.37K and bringing the position to 7,921 shares worth $627K. The position accounts for 0.49% of the portfolio, ranked #49.

Blue Chip Wealth Management first reported a position in MRK in Q1 2018 and has held it in 11 quarters since. The position peaked at $676K in Q4 2019. 2,558 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

  • Blue Chip Wealth Management held 7,921 shares of Merck worth $627K as of Q3 2020.
  • Blue Chip Wealth Management bought 43 Merck shares in Q3 2020, an estimated $3.37K.
  • Merck made up 0.49% of Blue Chip Wealth Management's portfolio in Q3 2020, its #49 holding.
  • Blue Chip Wealth Management first reported a position in Merck in Q1 2018 and has held it in 11 quarters since.
  • Blue Chip Wealth Management's Merck position peaked at $676K in Q4 2019.
  • 2,558 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on Blue Chip Wealth Management's 13F filing for Q3 2020, filed 12 Nov 2020.